{"disease":{"id":"intraperitoneal-chemotherapy-bevacizumab-ovarian-cancer","name":"intraperitoneal chemotherapy bevacizumab ovarian cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05410938","title":"Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Far Eastern Memorial Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}